6-MAPB

From Wikipedia, the free encyclopedia
Jump to: navigation, search
6-MAPB
6-MAPB structure.png
Systematic (IUPAC) name
1-(benzofuran-6-yl)-N-methylpropan-2-amine
Clinical data
Legal status Analogue of MDMA (AU) Analogue of amphetamine (CA) Temporary class drug (UK) Analogue of MDMA (US)
Identifiers
CAS number 1354631-79-0
ATC code ?
Chemical data
Formula C12H15NO 
Mol. mass 189.25

6-MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a presumably entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a "designer drug" but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives.[citation needed] 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.[1]


See also[edit]

References[edit]

  1. ^ "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 Jun 2013. Retrieved 2013-07-10.